insights_auto
Nega EDIT oshdi 6,61%?
Batafsil oʻrganishchevron_right
EDIT:NASDAQ
Editas Medicine Inc
2,58 US$
arrow_upward
+6,61%(+0,16) 1K
2,58 US$
0,00% (0,00)
bedtimeYopilgandan keyin
Savdolar yopilgan: 20-okt, 16:00:01 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoEDIT tikeri uchun statistika yaratilmoqda...
Ochish
2,40 US$
Yuqori
2,66 US$
Past
2,35 US$
Bozor kapitali
396,24 mln
Oʻrtacha hajm
3,03 mln
Hajmi
2,27 mln
52 haftalik eng yuqori
4,21 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,74 US$
Beta
2,00
Muomaladagi aksiyalar
153,58 mln
Xodimlar soni
87
Ochish
2,40 US$
Yuqori
2,66 US$
Past
2,35 US$
Bozor kapitali
396,24 mln
Oʻrtacha hajm
3,03 mln
Hajmi
2,27 mln
52 haftalik eng yuqori
4,21 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,74 US$
Beta
2,00
Muomaladagi aksiyalar
153,58 mln
Xodimlar soni
87
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
ad-hoc-news.de
·
3 soat oldin
Wells Fargo raises target for Editas Medicine stock from USD 4.00 to USD 6.00
Profil
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
Editas Medicine Inc haqida